Exclusive: Hospira wins French biosimilar drug tender at 45 percent discount

PARIS (Reuters) - A major French hospital group has chosen a cheap copycat version of a top-selling drug for treating its patients with rheumatoid arthritis, Crohn's disease and psoriasis in a victory for a new type of medicine known as biosimilars.   
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news